Press release
United States Liver Cancer Diagnostics Market PDF 2025-2031: Key Developments, Market Drivers, Industry Insights, Investment
Global Liver Cancer Diagnostics Market reached USD 8.6 billion in 2022 and is expected to reach USD 14.1 billion by 2030 growing with a CAGR of 6.6% during the forecast period 2024-2031Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/liver-cancer-diagnostics-market?kb
United States: Recent Industry Developments
✅ November 2025: Abbott Laboratories launched an advanced liquid biopsy test for early detection of liver cancer.
✅ October 2025: Exact Sciences expanded its biomarker panel for non-invasive liver cancer diagnostics.
✅ September 2025: FDA approved new AI-powered imaging software to enhance accuracy in liver cancer screening.
Japan: Recent Industry Developments
✅ November 2025: Sysmex Corporation introduced a next-gen blood test improving sensitivity for hepatocellular carcinoma detection.
✅ October 2025: Fujifilm developed AI algorithms integrated with imaging systems for more precise liver cancer diagnosis.
✅ September 2025: Japan's Ministry of Health supported nationwide screening programs utilizing novel diagnostic tools.
GCC: Recent Industry Developments
✅ November 2025: GCC healthcare providers adopted advanced liver cancer diagnostic kits to improve early-stage detection rates.
✅ October 2025: Saudi Arabia invested in genomic diagnostics infrastructure targeting liver cancer prevalence.
✅ September 2025: UAE collaborated with global diagnostic firms to enhance liver cancer awareness and diagnostic capabilities.
List of Top Key Player:
Abbott Laboratories, F. Hoffmann-La Roche Ltd., Qiagen N.V., Thermo Fisher Scientific, Inc., Siemens Healthineers, BD, Illumina, Inc., Koninklijke Philips N.V, Epigenomics AG, Fujifilm Medical Systems U.S.A., Inc., and Sysmex Corporation
Forecast Projection:
The Global Liver Cancer Diagnostics Market is poised for significant growth between 2025 and 2032. In 2024, the market maintained a steady upward trajectory, and with strategic initiatives by leading players accelerating adoption, the market is expected to soar throughout the forecast period. Companies leveraging these trends are well-positioned to capture emerging opportunities and maximize revenue potential.
Market Intelligence Research Process:
The Global Liver Cancer Diagnostics Market research report by DataM Intelligence combines primary and secondary data to deliver deep, actionable insights. It examines the full spectrum of factors shaping the industry, from government regulations and market conditions to competitive dynamics, historical trends, technological breakthroughs, upcoming innovations, and potential challenges. This comprehensive analysis not only highlights growth prospects but also identifies barriers, equipping businesses to navigate market volatility and capitalize on emerging opportunities.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=liver-cancer-diagnostics-market?kb
Key Segments:
By Test Type: (Alpha-fetoprotein (AFP) tumor marker test, Laboratory Tests, Biopsy, Imaging, Others)
By End User: (Hospitals, Cancer Research Institutes, Diagnostic Laboratories, Others)
Growth Regional Analysis:
1. North America: Leading with high screening and AI diagnostics, the U.S. market grows from USD 3.33B in 2025 to USD 4.66B by 2034, while Canada ramps up high-risk screening programs.
2. Europe: Germany captures a 27.5% share, expanding from USD 2.8B in 2025 to USD 5.1B by 2035 at a 6.2% CAGR, with France focusing on precision diagnostics.
3. Japan: Strong focus on hepatocellular carcinoma screening, growing at a 6.9% CAGR through 2035, led by key players like Fujifilm and Roche.
4. Taiwan & South Korea: Taiwan's precision medtech hubs support growth, while South Korea drives APAC's 10.54% CAGR with rare disease policies, with a USD 0.12B market in 2024.
Benefits of the Report:
Chapter 1 - Market Overview: Kickstarts the report with a comprehensive snapshot of the Global Liver Cancer Diagnostics Market, summarizing key segments by region, product type, and application. Highlights include market size, segment growth potential, and short- & long-term industry outlook.
Chapter 2 - Emerging Trends: Uncovers the game-changing trends and high-impact innovations shaping the future of the industry.
Chapter 3 - Competitive Landscape: Offers a deep dive into market competition, detailing revenue shares, strategic initiatives, and recent mergers & acquisitions.
Chapter 4 - Top Player Profiles: Features detailed company profiles, covering revenue, profit margins, product lines, and major milestones for leading market players.
Chapters 5 & 6 - Regional & Country Analysis: Breaks down revenue performance across global regions, providing insights on market sizes, opportunities, and growth prospects worldwide.
Chapter 7 - Segmentation Analysis: Explores market segmentation by type, revealing high-potential categories and guiding businesses towards lucrative areas.
Chapter 8 - Application Insights: Examines downstream markets and identifies promising sectors for expansion, showing how different applications are driving growth.
Chapter 9 - Supply Chain Mapping: Maps the entire industry supply chain, highlighting upstream and downstream activities for a holistic market perspective.
Chapter 10 - Key Takeaways: Concludes with critical insights and actionable strategies, equipping stakeholders to make informed decisions and stay ahead in the market.
Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/liver-cancer-diagnostics-market?kb
FAQ's
Q1: What is the current size of the Global Liver Cancer Diagnostics Market and its future potential?
A: The Global Liver Cancer Diagnostics Market was valued at USD$ 8.6 billion in 2022 and is projected to surge to USD$ 14.1 billion by 2030
Q2: How fast is the Global Liver Cancer Diagnostics Market expected to grow in the coming years?
A: The market is forecast to expand at a robust CAGR of 6.6% between 2025 and 2032
Q3: Which regions are dominating the Global Liver Cancer Diagnostics Market and which are fastest-growing?
A: Key markets include North America, Europe, and Asia-Pacific, led by the U.S., Japan, China, and Germany.
Request 2 Days Free Trials with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?kb
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Liver Cancer Diagnostics Market PDF 2025-2031: Key Developments, Market Drivers, Industry Insights, Investment here
News-ID: 4305558 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Japan Pharmaceuticals Market (2025-2032) | Market to Reach USD 206.70 billion by …
The Japan Pharmaceutical Market was valued at approximately USD 71.51 billion in 2024 and is projected to grow to USD 103.05 billion by 2030 at a CAGR of 6.3%, with some estimates forecasting it to reach USD 206.70 billion by 2032 during the Forecast period 2025-2032
Global Pharmaceutical market size grew from US$ 1,635.82 billion in 2023 to US$ 1,740.44 billion in 2024 and is projected to reach US$ 3,178.63 billion…
Global Aluminum Gallium Arsenide Market Set for Explosive Growth to USD 4.2 Bill …
The Global Aluminum Gallium Arsenide Market reached USD 1.9 billion in 2023 and is expected to reach USD 4.2 billion by 2031, growing with a CAGR of 10.2% during the forecast period 2024-2031.
Market growth is driven by surging demand in high-speed semiconductors, optoelectronics, and 5G/6G infrastructure, alongside expanding applications in solar cells, LEDs, and laser diodes. Advancements in epitaxial growth techniques, rising investments in photonics and RF devices, growing adoption…
Smart Office Market to Reach US$ 122.36 Billion by 2032 at 12.8% CAGR | IoT Enab …
Smart Office Market reached US$ 48.22 billion in 2024 and is expected to reach US$ 122.36 billion by 2032, growing at a CAGR of 12.8% during the forecast period 2025 to 2032.
Market growth is driven by rapid workplace digital transformation, increasing adoption of IoT enabled building management systems, and rising demand for energy efficient, secure, and highly connected office environments. Organizations are investing in smart lighting, intelligent HVAC controls, occupancy…
United States Friedreich's Ataxia (FA) Market Growth (2025-2033): Emerging Thera …
DataM Intelligence has published a new research report on "Friedreich's Ataxia Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
✅ North America is projected to maintain a…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
